Miaohan Qiu

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 5

Top Topics

Cardiovascular Events

Acute Coronary Syndrome

Antiplatelet Therapy

Top Venues

Cardiovascular therapeutics

Clinical cardiology

This page only lists publications with an associated author ORCID identifier.

Publications

Xuefei Mu, Miaohan Qiu, Yi Li, Ziqi Li, Bin Qi, Zilan Jing, Quanmin Jing
N-terminal pro-B-type natriuretic peptide improves the predictive value of CHA 2 DS 2 -VASc risk score for long-term cardiovascular events in acute coronary syndrome patients with atrial fibrillation. Clinical cardiology (2023)
Jing Li, Sanbao Chen, Sicong Ma, Mingque Yang, Zizhao Qi, Kun Na, Miaohan Qiu, Yi Li, Ya-Ling Han
Safety and Efficacy of Bivalirudin versus Unfractionated Heparin Monotherapy in Patients with CAD and DM Undergoing PCI: A Retrospective Observational Study. Cardiovascular therapeutics 2022 (2022)
Jing Li, Sanbao Chen, Sicong Ma, Mingque Yang, Zizhao Qi, Kun Na, Miaohan Qiu, Yi Li, Ya-Ling Han
Safety and Efficacy of Bivalirudin versus Unfractionated Heparin Monotherapy in Patients with CAD and DM Undergoing PCI: A Retrospective Observational Study. Cardiovascular therapeutics 2022 (2022)
Jing Li, Sanbao Chen, Sicong Ma, Mingque Yang, Zizhao Qi, Kun Na, Miaohan Qiu, Yi Li, Ya-Ling Han
Safety and Efficacy of Bivalirudin versus Unfractionated Heparin Monotherapy in Patients with CAD and DM Undergoing PCI: A Retrospective Observational Study. Cardiovascular therapeutics 2022 (2022)
Yaling Han, Jiyan Chen, Miaohan Qiu, Yi Li, Jing Li, Yingqing Feng, Jian Qiu, Liang Meng, Yihong Sun, Guizhou Tao, Zhaohui Wu, Chunyu Yang, Jincheng Guo, Kui Pu, Shaoliang Chen, Xiaozeng Wang
Predicting long-term ischemic events using routine clinical parameters in patients with coronary artery disease: The OPT-CAD risk score. Cardiovascular therapeutics 36 (5) (2018)